Evidence map›Paper›PMID 39282870›Full record

ArticleJournal of agricultural and food chemistry2024

Detailed Analysis of Prebiotic Fructo- and Galacto-Oligosaccharides in the Human Small Intestine.

Mara P H van Trijp, Melany Rios-Morales, Madelon J Logtenberg, Shohreh Keshtkar, Lydia A Afman, Ben Witteman, Barbara Bakker, Dirk-Jan Reijngoud, Henk Schols, Guido J E J Hooiveld

Abstract read
In one paragraph

Article in Journal of agricultural and food chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mara P H van TrijpDivision of Human Nutrition and Health, Wageningen University, Wageningen 6708 WE, The Netherlands.ORCID 0009-0003-2633-798X
Melany Rios-MoralesLaboratory of Pediatrics, Center for Liver, Digestive and Metabolic Diseases, University of Groningen, University Medical Center Groningen, Groningen 9713 GZ, The Netherlands.
Madelon J LogtenbergLaboratory of Food Chemistry, Wageningen University, Wageningen 6708 WG, The Netherlands.
Shohreh KeshtkarDivision of Human Nutrition and Health, Wageningen University, Wageningen 6708 WE, The Netherlands.
Lydia A AfmanDivision of Human Nutrition and Health, Wageningen University, Wageningen 6708 WE, The Netherlands.
Ben WittemanDivision of Human Nutrition and Health, Wageningen University, Wageningen 6708 WE, The Netherlands.
Barbara BakkerLaboratory of Pediatrics, Center for Liver, Digestive and Metabolic Diseases, University of Groningen, University Medical Center Groningen, Groningen 9713 GZ, The Netherlands.
Dirk-Jan ReijngoudLaboratory of Pediatrics, Center for Liver, Digestive and Metabolic Diseases, University of Groningen, University Medical Center Groningen, Groningen 9713 GZ, The Netherlands.
Henk ScholsLaboratory of Food Chemistry, Wageningen University, Wageningen 6708 WG, The Netherlands.ORCID 0000-0002-5712-1554
Guido J E J HooiveldDivision of Human Nutrition and Health, Wageningen University, Wageningen 6708 WE, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS) are food ingredients that improve human health, but their degradation throughout the human small intestine is not well understood. We studied the breakdown kinetics of FOS and GOS in the intestines of seven healthy Dutch adults. Subjects were equipped with a catheter in the distal ileum or proximal colon and consumed 5 g of chicory-derived FOS (degree of polymerization (DP) DP2-10), and 5 g of GOS (DP2-6). Postprandially, intestinal content was frequently collected until 350 min and analyzed for mono-, di-, and oligosaccharides. FOS and GOS had recoveries of 96 ± 25% and 76 ± 28%, respectively. FOS DP ≥ 2 and GOS DP ≥ 3 abundances in the distal small intestine or proximal colon matched the consumed doses, while GOS dimers (DP2) had lower recoveries, namely 22.8 ± 11.1% for β-D-gal-(1↔1)-α-D-glc+β-D-gal-(1↔1)-β-D-glc, 19.3 ± 19.1% for β-D-gal-(1 → 2)-D-glc+β-D-gal-(1 → 3)-D-glc, 43.7 ± 24.6% for β-D-gal-(1 → 6)-D-gal, and 68.0 ± 38.5% for β-D-gal-(1 → 4)-D-gal. Lactose was still present in the distal small intestine of all of the participants. To conclude, FOS DP ≥ 2 and GOS DP ≥ 3 were not degraded in the small intestine of healthy adults, while most prebiotic GOS DP2 was hydrolyzed in a structure-dependent manner. We provide evidence on the resistances of GOS with specific β-linkages in the human intestine, supporting the development of GOS prebiotics that resist small intestine digestion.

Indexed as

Intestine, SmallOligosaccharidesPrebioticsAdultFemaleGalactoseHumansKineticsMaleMiddle AgedYoung AdultGalactoseOligosaccharidesPrebioticsdigestionhumanileumlactoseoligosaccharidesprebioticssmall intestine

Identifiers

PMID39282870
PMCPMC11440495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.